Switching Patterns of Mixed Amphetamine Salt Products in the FDA’s Sentinel Distributed Database

    Basic Details
    Date
    Saturday, August 27, 2022
    Type
    Presentation
    Description

    ​​​​​This poster examines utilization and switching patterns among individuals with attention deficit hyperactivity disorder or narcolepsy treated with mixed amphetamine salt immediate release products in the FDA Sentinel Distributed Database. It was presented at the 38th International Conference on Pharmacoepidemiology and Therapeutic Risk Management. 

    Presenter(s)

    ​​​​​​Jennifer G. Lyons, Maria E. Kempner, Talia Menzin, Amanda Carruth, Aaron Hansbury, Sruthi Adimadhyam, Sarah Dutcher, Kira Leishear, Corinne Woods, James Osterhout, Modupeola Adereti, Sukhminder K. Sandhu, Silvia Perez-Vilar